XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations - Sale of Infusionz to Bloomios (Table)
9 Months Ended
Mar. 31, 2023
Discontinued Operations - Sale of Infusionz to Bloomios  
Schedule Of Sale of Infusionz to Bloomios

Tangible assets, inventory / working capital*

 

$(1,344,000 )

Tangible assets, warehouse and manufacturing equipment, net of accumulated depreciation*

 

 

(679,327 )

Goodwill

 

 

(2,413,814 )

Intangible assets, net of accumulated amortization

 

 

(946,996 )

Accrued and incurred expenses related to the transaction and additional working capital*

 

 

(2,051,500 )

Consideration received, including cash, debt and equity, net

 

 

15,000,000

 

Total gain recognized

 

$7,564,363

 

Advance for payroll

 

$50,000

 

Operating expense

 

 

608,517

 

Management fees

 

 

428,500

 

Excess working capital

 

 

388,565

 

Accrued interest

 

 

141,635

 

Total amounts due from Bloomios

 

$1,617,217

 

Schedule Of Investments - Bloomios

Senior secured convertible debenture, net of unamortized original issue discount

 

$4,955,450

 

Series D convertible preferred stock

 

 

8,500,000

 

Convertible Secured Subordinate Promissory Note

 

 

5,000,000

 

Reserve on Investments - Bloomios

 

 

(8,500,000 )

Total Investments - Bloomios

 

$9,955,450

 

Schedule Of Discontinued Operations

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Discontinued Operations

 

 

 

 

 

 

Revenue

 

$-

 

 

$5,844,690

 

Cost of sales

 

 

-

 

 

 

3,086,645

 

Sales, general and administrative expenses

 

 

-

 

 

 

1,764,754

 

Depreciation and amortization

 

 

(288,127

 

 

200,353

 

Income (loss) from discontinued operations

 

288,127

 

 

 

792,918

 

Accounts receivable net of allowance for doubtful accounts

 

 

-

 

 

 

941,465

 

Fixed assets, net of accumulated depreciation

 

 

-

 

 

 

670,528

 

Total assets

 

 

-

 

 

 

8,330,573

 

Total liabilities

 

$-

 

 

$167,008

 

 

 

Nine Months Ended March 31,

 

 

 

2023

 

 

2022

 

Discontinued Operations

 

 

 

 

 

 

Revenue

 

 $3,042,878

 

 

 $16,107,558

 

Cost of sales

 

 $

1,803,643

 

 

 $

8,127,404

 

Sales, general and administrative expenses

 

 $

1,300,102

 

 

 $

2,946,810

 

Depreciation and amortization

 

 $

10,576

 

 

 $

573,171

 

Income (loss) from discontinued operations, net of tax

 

 $

(50,291 )

 

 $

4,115,245

 

Accounts receivable net of allowance for doubtful accounts

 

 

-

 

 

 $

941,465

 

Fixed assets, net of accumulated depreciation

 

 

-

 

 

 $

670,528

 

Total assets

 

 

-

 

 

 $

8,330,573

 

Total liabilities

 

 $-

 

 

 $167,008